BRCA1/2 Mutations Associated with Progression-Free Survival in Ovarian Cancer Patients in the AGO-OVAR 16 Study.

Gynecologic Oncology(2016)

引用 46|浏览27
暂无评分
摘要
•To identify genetic markers associated with prognosis in ovarian cancer.•Longer progression-free survival was observed in patients with BRCA1/2 mutations.•Genetic counseling plays an important role and should be offered to all patients.
更多
查看译文
关键词
GWAS,Ovarian cancer,Progression-free survival,Germline BRCA mutation,Pazopanib
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要